India
Wikileaks on USTR negotiations with India Commerce Minister Anand Sharma
Submitted by James Love on 28. August 2011 - 22:50Among the cables recently published by Wilileaks is one written on November 24, 2009, detailing negotiations between USTR and Anand Sharma, the Cabinet Minister for Commerce and Industry of the Government of India. The complete cable is available here: http://wikileaks.org/cable/2009/11/09NEWDELHI2375.html
Karl De Gucht writes Andris Piebalgs on topic of European Union IPR demands on India and other developing countries
Submitted by James Love on 27. May 2011 - 16:15KEI has received a copy of a May 16, 2011 letter from Karl De Gucht to Andris Piebalgs, which discusses (1) the EU-India FTA, and (2) Relations between IPR and development policies.
The production of generic drugs in India: A new trade agreement with the EU would hinder access to drugs in developing countries
Submitted by KEI Staff on 23. March 2011 - 5:00On March 22, 2011, the British Medical Journal (BMJ) published the following guest editorial about the EU/India Free Trade Agreement negotiations.
Ska Keller tables MEP question on ethical aspects of pharmaceutical test data protection
Submitted by James Love on 20. January 2011 - 5:04On Tuesday the 18th of January 2010,German Green MEP Franziska Keller tabled this Parliamentary question: 
Extracts of India's Intervention to the WTO TRIPS Council: ACTA
Submitted by thiru on 28. October 2010 - 1:58On Wednesday, 27 October 2010, the WTO TRIPS Council held its annual review of the Paragraph 6 System. IP-Watch has a link to the detailed program of the annual review. This annual review of the Paragraph 6 system lasted till around 8 PM Geneva time. More details of this closed door meeting will be provided in due course.
US NGO’s Call For George Washington University to Cease Industry-Sponsored Intellectual Property Training in India
Submitted by Judit Rius on 9. June 2010 - 12:44On June 7, 2010 medicine access advocacy groups joined together in asking that George Washington University (GWU) put a stop to its industry-sponsored intellectual property (IP) summits and to take an academic, evidenced-based approach to conferences it conducts in India.
KEI statement on possible WTO disputes against the EU seizures of goods in transit
Submitted by thiru on 12. May 2010 - 10:1012 May 2010
Statement of Knowledge Ecology International on possible WTO disputes against the EU seizures of goods in transit
Thiru Balasubramaniam, Geneva Representative
“In a world with territorial patent rights, it is important that the rules for ‘goods in transit’ permit the transport of medicines from places where they can be made to places where they will be used. The EU's systematic seizure of at least 17 drug consignments is indefensible and undermines the very principle of free trade, the raison d’être of the World Trade Organization.
Tie up with Pfizer in India a mistake, says USPTO
Submitted by James Love on 22. March 2010 - 10:46On March 5, 2010, KEI published documents received from a FOIA request, about a collaboration between the USPTO and Pfizer to hold workshops in India. On March 11, the USPTO responded with a statement of regret concerning the collaboration, which it termed a mistake.
The Business Standard of India has written an article about the USPTO/Pfizer collaboration here:
Indian NGOs confront GWU Law School efforts to push maximalist IPR norms in India
Submitted by Judit Rius on 4. March 2010 - 17:10The ties between Universities and businesses are often complex and blurred. Private companies or trade associations fund research and seminars, and have consulting relationships with faculty members, trying to shape public policy and judicial decisions on a wide range of issues. A particularly interesting industry/university connection concerns something called the "India Project," that is associated with the George Washington University (GWU) Law School.
Intervention of India at MSF workshop at the WTO Public Forum
Submitted by thiru on 30. September 2009 - 9:57India delivered the following intervention at MSF's workshop at the World Trade Organization Public Forum today. The title of the MSF workshop was "Controversy at customs - the detention of medicines in transit: what impact on access to medicines?"
WTO Public Forum ( MSF event)
Controversy at customs - the detention of medicines in transit: what impact on access to medicines?
Wednesday 30 September 2009, 14:15 to 16:15
WTO building, Room A
